Xenon Pharmaceuticals(XENE)
BC - BurnabyPharmaceutical
Focus: Xenon Pharmaceuticals is a public biotech focused on small-molecule therapeutics for rare genetic diseases, particularly in neurology and epilepsy, headquartered in Burnaby, BC. The company operates with a lean structure and is advancing multiple late-stage programs toward potential commercialization.
Profile data last refreshed 18h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
32+1 this month
Stable — net +1 jobs in 30d
11 added, 10 removed. Backfill posture.
Should You Work at Xenon Pharmaceuticals?
AI assessmentBest suited for clinical development and commercial professionals seeking high-risk, high-reward exposure to late-stage epilepsy and neuropsychiatric programs with near-term approval potential.
Why Work Here
- Strong late-stage pipeline with 11 Phase 3 programs providing multiple shots on goal for clinical catalysts and regulatory approvals.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
11 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Pipeline & Clinical Trials
XEN901
Healthy VolunteersClinical Trials (1)
NCT03467100Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901
Phase 1Help build intelligence for Xenon Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.